← All compounds
Extensively Studied

NAD+

Essential Cellular Coenzyme | Anti-Aging Therapy

Nicotinamide Adenine Dinucleotide (NAD+) is a vital coenzyme found in every cell that plays a crucial role in energy production, DNA repair, and cellular metabolism. As NAD+ levels naturally decline with age, supplementation can support cellular health, boost energy, enhance cognitive function, and promote longevity.

Daily dose

100-1000mg

Frequency

1-3x weekly

Cycle length

4-12 weeks

Storage

2-8°C

Key benefits

Highest bioavailability (100%), rapid cellular uptake, immediate energy enhancement, bypasses digestive limitations

How it works

Direct delivery to bloodstream ensures maximum cellular availability for energy production, DNA repair, and sirtuin activation

Dosage protocols

Goal

General Wellness & Energy

Dose

100-250mg · 1-2x weekly

Route

IV or IM

Goal

Anti-Aging Protocol

Dose

250-500mg · 2-3x weekly

Route

IV infusion

Goal

Cognitive Enhancement

Dose

500-1000mg · 1-2x weekly

Route

IV infusion

Goal

Athletic Performance

Dose

250-500mg · 2x weekly

Route

IM injection

Goal

Recovery & Repair

Dose

500-1000mg · 3x weekly

Route

IV infusion

Goal

Maintenance Therapy

Dose

100-250mg · 1x weekly

Route

SubQ or IM

Research indications

energy Metabolism

Cellular Energy ProductionRestores mitochondrial function and ATP synthesis capacity
Metabolic OptimizationEnhances glucose and fat metabolism efficiency
Exercise PerformanceImproves oxygen utilization and endurance capacity

anti Aging

DNA Repair EnhancementActivates PARP enzymes for improved DNA repair mechanisms
Sirtuin ActivationSupports longevity pathways and cellular stress resistance
Senescence ReductionMay help clear senescent cells and improve tissue function

neurological Support

Cognitive EnhancementImproves mental clarity, focus, and memory formation
NeuroprotectionSupports neuronal health and reduces neuroinflammation
Neurotransmitter SupportOptimizes brain chemistry for mood and cognitive function

Administration

injectable
oral
topical
nasal

Interactions

Synergistic
BPC-157Combined protocols enhance cellular repair and energy production
Synergistic
TB-500Complementary effects on tissue regeneration and mitochondrial function
Compatible
TirzepatideNAD+ supports metabolic pathways enhanced by GLP-1 agonists
Synergistic
IpamorelinGrowth hormone pathways benefit from improved cellular energy metabolism
Compatible
CJC-1295Enhanced recovery and anti-aging effects when combined
Avoid Combination
AlcoholAlcohol consumption significantly reduces NAD+ levels and effectiveness
Synergistic
L-CarnitineBoth support mitochondrial function - NAD+ in electron transport chain, L-Carnitine in fatty acid transport for beta-oxidation

Safety notes

Start with lower doses to assess tolerance

IV administration requires medical supervision

Monitor for injection site reactions

Avoid alcohol consumption during treatment

Maintain consistent dosing schedule for best results

Research studies

Intranasal NAD+ for Traumatic Brain Injury (2012)

Rats | 20 mg/kg intranasal | Post-TBI treatment | Hippocampal neuroprotection

Demonstrated that intranasal NAD+ delivery protected hippocampal neurons (CA1, CA3, dentate gyrus) and reduced microglial activation following traumatic brain injury.

View study →

Nicotinamide Riboside Safety & Metabolism Study (2019)

Human | 100-1000mg oral daily | 8 weeks | Well-tolerated, increased NAD+

Randomized, double-blind, placebo-controlled clinical trial demonstrating long-term NR administration is safe and effectively elevates NAD+ metabolites in healthy overweight adults.

View study →

Age-Associated NAD+ Decline in Human Tissue (2012)

Human tissue analysis | Multiple organs studied | Cross-sectional | 10-50% decline with age

Foundational study by Massudi et al. showing NAD+ decreases in skin, brain, heart, and liver by 10-50% during adult aging, correlating with increased oxidative stress and PARP activity.

View study →

Nicotinamide Riboside Bioavailability in Humans (2016)

Human | 100-1000mg oral | Single dose pharmacokinetics | Dose-dependent NAD+ elevation

First clinical trial of NR pharmacokinetics demonstrating dose-dependent increases in blood NAD+ metabolome and identifying NAAD as a sensitive biomarker of effective NAD+ repletion.

View study →

NMN Efficacy in Middle-Aged Adults (2022)

Human | 300-900mg oral daily | 60 days | Multicenter RCT

Randomized, multicenter, double-blind trial showing NMN supplementation safely and effectively elevated NAD+ metabolism with dose-dependent improvements in physical performance.

View study →